James E Flynn - Net Worth and Insider Trading

Over the past 18 months, James E Flynn made 4 insider transaction in Oncorus Inc (ONCR) with a net sale of 551,663.

In summary, during the past 3 months, insiders sold 0 shares of Oncorus Inc (ONCR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 551,663 shares of Oncorus Inc (ONCR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 551,663 shares.

Oncorus Inc (ONCR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made 1 insider transaction in Larimar Therapeutics Inc (LRMR) with a net purchase of 4,290,617. Other recent insider transactions involving Larimar Therapeutics Inc (LRMR) include a net purchase of 5,000 shares made by Carole Ben-maimon , a net purchase of 5,000 shares made by Gopi Shankar , and a net purchase of 5,000 shares made by Michael Celano .

In summary, during the past 3 months, insiders sold 0 shares of Larimar Therapeutics Inc (LRMR) in total and bought 4,292,617 shares, with a net purchase of 4,292,617 shares. During the past 18 months, 0 shares of Larimar Therapeutics Inc (LRMR) were sold and 4,310,367 shares were bought by its insiders, resulting in a net purchase of 4,310,367 shares.

Larimar Therapeutics Inc (LRMR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in CalciMedica Inc (CALC). Other recent insider transactions involving CalciMedica Inc (CALC) include a net purchase of 65,404 shares made by Eric W Roberts , a net purchase of 20,768 shares made by A. Rachel Leheny , and a net purchase of 691,098 shares made by Fred A Middleton .

In summary, during the past 3 months, insiders sold 0 shares of CalciMedica Inc (CALC) in total and bought 4,000 shares, with a net purchase of 4,000 shares. During the past 18 months, 0 shares of CalciMedica Inc (CALC) were sold and 1,505,415 shares were bought by its insiders, resulting in a net purchase of 1,505,415 shares.

CalciMedica Inc (CALC)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Acutus Medical Inc (AFIB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Acutus Medical Inc (AFIB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Acutus Medical Inc (AFIB)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Annexon Inc (ANNX). Other recent insider transactions involving Annexon Inc (ANNX) include a net sale of 47,471 shares made by Ted Yednock , a net sale of 7,367 shares made by Jennifer Lew , and a net sale of 5,923 shares made by Michael Overdorf .

In summary, during the past 3 months, insiders sold 17,898 shares of Annexon Inc (ANNX) in total and bought 6,400 shares, with a net sale of 11,498 shares. During the past 18 months, 73,114 shares of Annexon Inc (ANNX) were sold and 3,303,458 shares were bought by its insiders, resulting in a net purchase of 3,230,344 shares.

Annexon Inc (ANNX)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Deerfield Healthcare Technology Acquisitions Corp (DFHTU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Deerfield Healthcare Technology Acquisitions Corp (DFHTU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Deerfield Healthcare Technology Acquisitions Corp (DFHTU)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Nkarta Inc (NKTX). Other recent insider transactions involving Nkarta Inc (NKTX) include a net sale of 10,257 shares made by James Trager , a net sale of 5,497 shares made by David Shook , and a net sale of 15,092 shares made by Paul J Hastings .

In summary, during the past 3 months, insiders sold 4,143 shares of Nkarta Inc (NKTX) in total and bought 5,000,000 shares, with a net purchase of 4,995,857 shares. During the past 18 months, 42,076 shares of Nkarta Inc (NKTX) were sold and 5,000,000 shares were bought by its insiders, resulting in a net purchase of 4,957,924 shares.

Nkarta Inc (NKTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Generation Bio Co (GBIO). Other recent insider transactions involving Generation Bio Co (GBIO) include a net sale of 10,590 shares made by Antoinette Paone , a net purchase of 20,000 shares made by Dannielle Appelhans , and a net purchase of 342,960 shares made by Rowland Charles A Jr .

In summary, during the past 3 months, insiders sold 0 shares of Generation Bio Co (GBIO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 12,455 shares of Generation Bio Co (GBIO) were sold and 551,455 shares were bought by its insiders, resulting in a net purchase of 539,000 shares.

Generation Bio Co (GBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Lumos Pharma Inc (LUMO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Lumos Pharma Inc (LUMO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Lumos Pharma Inc (LUMO)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of DFP Healthcare Acquisitions Corp (DFPHU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of DFP Healthcare Acquisitions Corp (DFPHU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

DFP Healthcare Acquisitions Corp (DFPHU)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Revolution Medicines Inc (RVMD). Other recent insider transactions involving Revolution Medicines Inc (RVMD) include a net sale of 109,411 shares made by Margaret A Horn , a net sale of 97,493 shares made by Stephen Michael Kelsey , and a net sale of 12,934 shares made by Jeff Cislini .

In summary, during the past 3 months, insiders sold 68,164 shares of Revolution Medicines Inc (RVMD) in total and bought 0 shares, with a net sale of 68,164 shares. During the past 18 months, 354,957 shares of Revolution Medicines Inc (RVMD) were sold and 650,000 shares were bought by its insiders, resulting in a net purchase of 295,043 shares.

Revolution Medicines Inc (RVMD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Schrodinger Inc (SDGR). Other recent insider transactions involving Schrodinger Inc (SDGR) include a net sale of 60,758 shares made by Yvonne Tran , a net sale of 20,901 shares made by Kenneth Patrick Lorton , and a net sale of 66,886 shares made by Ramy Farid .

In summary, during the past 3 months, insiders sold 6,966 shares of Schrodinger Inc (SDGR) in total and bought 0 shares, with a net sale of 6,966 shares. During the past 18 months, 168,702 shares of Schrodinger Inc (SDGR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 168,702 shares.

Schrodinger Inc (SDGR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Black Diamond Therapeutics Inc (BDTX). Other recent insider transactions involving Black Diamond Therapeutics Inc (BDTX) include a net purchase of 3,140,000 shares made by Biotech Growth N V , a net purchase of 1,000,000 shares made by Ali Behbahani , and a net purchase of 935,850 shares made by Ra Capital Healthcare Fund Lp .

In summary, during the past 3 months, insiders sold 0 shares of Black Diamond Therapeutics Inc (BDTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 25,000 shares of Black Diamond Therapeutics Inc (BDTX) were sold and 5,132,213 shares were bought by its insiders, resulting in a net purchase of 5,107,213 shares.

Black Diamond Therapeutics Inc (BDTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Homology Medicines Inc (FIXX). Other recent insider transactions involving Homology Medicines Inc (FIXX) include a net sale of 21,335 shares made by Paul Alloway , a net sale of 23,653 shares made by Arthur Tzianabos , and a net sale of 5,068 shares made by Albert Seymour .

In summary, during the past 3 months, insiders sold 0 shares of Homology Medicines Inc (FIXX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 3,328 shares of Homology Medicines Inc (FIXX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 3,328 shares.

Homology Medicines Inc (FIXX)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of AdaptHealth Corp (DFBHU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of AdaptHealth Corp (DFBHU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

AdaptHealth Corp (DFBHU)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Cabaletta Bio Inc (CABA). Other recent insider transactions involving Cabaletta Bio Inc (CABA) include a net sale of 110,000 shares made by Gwendolyn Binder ,

In summary, during the past 3 months, insiders sold 0 shares of Cabaletta Bio Inc (CABA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 110,000 shares of Cabaletta Bio Inc (CABA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 110,000 shares.

Cabaletta Bio Inc (CABA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Frequency Therapeutics Inc (FREQ). Other recent insider transactions involving Frequency Therapeutics Inc (FREQ) include a net sale of 97,675 shares made by David L. Lucchino , a net sale of 8,202 shares made by Richard J. Mitrano , and a net sale of 26,723 shares made by Christopher R. Loose .

In summary, during the past 3 months, insiders sold 0 shares of Frequency Therapeutics Inc (FREQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 132,600 shares of Frequency Therapeutics Inc (FREQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 132,600 shares.

Frequency Therapeutics Inc (FREQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Mirum Pharmaceuticals Inc (MIRM). Other recent insider transactions involving Mirum Pharmaceuticals Inc (MIRM) include a net sale of 10,305 shares made by Peter Radovich , a net sale of 8,137 shares made by Jolanda Howe , and a net purchase of 161,963 shares made by Patrick J Heron .

In summary, during the past 3 months, insiders sold 4,303 shares of Mirum Pharmaceuticals Inc (MIRM) in total and bought 4,000 shares, with a net sale of 303 shares. During the past 18 months, 393,444 shares of Mirum Pharmaceuticals Inc (MIRM) were sold and 175,963 shares were bought by its insiders, resulting in a net sale of 217,481 shares.

Mirum Pharmaceuticals Inc (MIRM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Aclaris Therapeutics Inc (ACRS). Other recent insider transactions involving Aclaris Therapeutics Inc (ACRS) include a net sale of 53,837 shares made by Joseph Monahan , a net sale of 129,240 shares made by Neal Walker , and a net purchase of 12,800 shares made by Douglas J. Manion .

In summary, during the past 3 months, insiders sold 0 shares of Aclaris Therapeutics Inc (ACRS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 243,164 shares of Aclaris Therapeutics Inc (ACRS) were sold and 36,995 shares were bought by its insiders, resulting in a net sale of 206,169 shares.

Aclaris Therapeutics Inc (ACRS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Shockwave Medical Inc (SWAV). Other recent insider transactions involving Shockwave Medical Inc (SWAV) include a net sale of 72,000 shares made by Isaac Zacharias , a net sale of 49,000 shares made by Frank T Watkins , and a net sale of 21,113 shares made by Dan Puckett .

In summary, during the past 3 months, insiders sold 89,636 shares of Shockwave Medical Inc (SWAV) in total and bought 0 shares, with a net sale of 89,636 shares. During the past 18 months, 312,716 shares of Shockwave Medical Inc (SWAV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 312,716 shares.

Shockwave Medical Inc (SWAV)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Xeris Biopharma Holdings Inc (XERS). Other recent insider transactions involving Xeris Biopharma Holdings Inc (XERS) include a net purchase of 30,000 shares made by Paul R Edick , a net purchase of 11,000 shares made by John P. Schmid , and a net purchase of 30,769 shares made by Shannon John Patrick Jr .

In summary, during the past 3 months, insiders sold 0 shares of Xeris Biopharma Holdings Inc (XERS) in total and bought 4,500 shares, with a net purchase of 4,500 shares. During the past 18 months, 0 shares of Xeris Biopharma Holdings Inc (XERS) were sold and 110,579 shares were bought by its insiders, resulting in a net purchase of 110,579 shares.

Xeris Biopharma Holdings Inc (XERS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Arvinas Inc (ARVN). Other recent insider transactions involving Arvinas Inc (ARVN) include a net sale of 11,074 shares made by John G Houston , a net sale of 3,447 shares made by Sean A Cassidy , and a net sale of 3,023 shares made by Ronald Peck .

In summary, during the past 3 months, insiders sold 10,298 shares of Arvinas Inc (ARVN) in total and bought 0 shares, with a net sale of 10,298 shares. During the past 18 months, 20,296 shares of Arvinas Inc (ARVN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 20,296 shares.

Arvinas Inc (ARVN)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Aerie Pharmaceuticals Inc (AERI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aerie Pharmaceuticals Inc (AERI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aerie Pharmaceuticals Inc (AERI)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Constellation Pharmaceuticals Inc (CNST) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Constellation Pharmaceuticals Inc (CNST) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Constellation Pharmaceuticals Inc (CNST)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Avadel Pharmaceuticals PLC (AVDL). Other recent insider transactions involving Avadel Pharmaceuticals PLC (AVDL) include a net purchase of 9,000 shares made by Thomas S Mchugh , a net sale of 103,975 shares made by Mark Anthony Mccamish , and a net purchase of 33,000 shares made by Eric J Ende .

In summary, during the past 3 months, insiders sold 0 shares of Avadel Pharmaceuticals PLC (AVDL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 103,975 shares of Avadel Pharmaceuticals PLC (AVDL) were sold and 70,500 shares were bought by its insiders, resulting in a net sale of 33,475 shares.

Avadel Pharmaceuticals PLC (AVDL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Protara Therapeutics Inc (TARA). Other recent insider transactions involving Protara Therapeutics Inc (TARA) include a net sale of 15,473 shares made by Opaleye Management Inc. ,

In summary, during the past 3 months, insiders sold 0 shares of Protara Therapeutics Inc (TARA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 15,473 shares of Protara Therapeutics Inc (TARA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 15,473 shares.

Protara Therapeutics Inc (TARA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Kiniksa Pharmaceuticals Ltd (KNSA). Other recent insider transactions involving Kiniksa Pharmaceuticals Ltd (KNSA) include a net sale of 96,513 shares made by John Paolini , a net sale of 83,336 shares made by Sanj K Patel , and a net sale of 24,101 shares made by Michael R Megna .

In summary, during the past 3 months, insiders sold 108,277 shares of Kiniksa Pharmaceuticals Ltd (KNSA) in total and bought 0 shares, with a net sale of 108,277 shares. During the past 18 months, 225,909 shares of Kiniksa Pharmaceuticals Ltd (KNSA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 225,909 shares.

Kiniksa Pharmaceuticals Ltd (KNSA)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Mallinckrodt PLC (MNKKQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Mallinckrodt PLC (MNKKQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Mallinckrodt PLC (MNKKQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Catalyst Biosciences Inc (CBIO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Catalyst Biosciences Inc (CBIO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Catalyst Biosciences Inc (CBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Rhythm Pharmaceuticals Inc (RYTM). Other recent insider transactions involving Rhythm Pharmaceuticals Inc (RYTM) include a net sale of 81,925 shares made by Jennifer Chien , a net sale of 154,303 shares made by Joseph Shulman , and a net sale of 72,562 shares made by Hunter C Smith .

In summary, during the past 3 months, insiders sold 243,187 shares of Rhythm Pharmaceuticals Inc (RYTM) in total and bought 0 shares, with a net sale of 243,187 shares. During the past 18 months, 404,456 shares of Rhythm Pharmaceuticals Inc (RYTM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 404,456 shares.

Rhythm Pharmaceuticals Inc (RYTM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Societal CDMO Inc (SCTL). Other recent insider transactions involving Societal CDMO Inc (SCTL) include a net sale of 230,000 shares made by Awm Investment Company, Inc. , a net purchase of 125,660 shares made by Enloe J David Jr , and a net purchase of 6,250,000 shares made by Mathew Paul Arens .

In summary, during the past 3 months, insiders sold 0 shares of Societal CDMO Inc (SCTL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 370,000 shares of Societal CDMO Inc (SCTL) were sold and 6,792,882 shares were bought by its insiders, resulting in a net purchase of 6,422,882 shares.

Societal CDMO Inc (SCTL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in eHealth Inc (EHTH). Other recent insider transactions involving eHealth Inc (EHTH) include a net purchase of 22,932 shares made by Dale B Wolf , a net purchase of 7,500 shares made by Gavin G. Galimi , and a net purchase of 80,000 shares made by Soistman Francis S Jr .

In summary, during the past 3 months, insiders sold 0 shares of eHealth Inc (EHTH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 5,000 shares of eHealth Inc (EHTH) were sold and 115,432 shares were bought by its insiders, resulting in a net purchase of 110,432 shares.

eHealth Inc (EHTH)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of CAS Medical Systems Inc (CASM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of CAS Medical Systems Inc (CASM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

CAS Medical Systems Inc (CASM)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Invuity Inc (IVTY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Invuity Inc (IVTY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Invuity Inc (IVTY)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Vanda Pharmaceuticals Inc (VNDA). Other recent insider transactions involving Vanda Pharmaceuticals Inc (VNDA) include a net sale of 51,638 shares made by Kevin Patrick Moran , a net sale of 56,426 shares made by Timothy Williams , and a net sale of 196,036 shares made by Mihael Hristos Polymeropoulos .

In summary, during the past 3 months, insiders sold 121,098 shares of Vanda Pharmaceuticals Inc (VNDA) in total and bought 0 shares, with a net sale of 121,098 shares. During the past 18 months, 377,072 shares of Vanda Pharmaceuticals Inc (VNDA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 377,072 shares.

Vanda Pharmaceuticals Inc (VNDA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Alpine Immune Sciences Inc (ALPN). Other recent insider transactions involving Alpine Immune Sciences Inc (ALPN) include a net sale of 281,514 shares made by James Paul Rickey , a net sale of 213,302 shares made by Mitchell Gold , and a net sale of 1,546,347 shares made by Orbimed Advisors Llc .

In summary, during the past 3 months, insiders sold 19 shares of Alpine Immune Sciences Inc (ALPN) in total and bought 0 shares, with a net sale of 19 shares. During the past 18 months, 3,587,529 shares of Alpine Immune Sciences Inc (ALPN) were sold and 750,000 shares were bought by its insiders, resulting in a net sale of 2,837,529 shares.

Alpine Immune Sciences Inc (ALPN)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Audentes Therapeutics Inc (BOLD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Audentes Therapeutics Inc (BOLD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Audentes Therapeutics Inc (BOLD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Axogen Inc (AXGN). Other recent insider transactions involving Axogen Inc (AXGN) include a net sale of 100,448 shares made by Gregory Gene Freitag , a net sale of 128,948 shares made by Peter J Mariani , and a net sale of 42,343 shares made by Michael Patrick Donovan .

In summary, during the past 3 months, insiders sold 118,082 shares of Axogen Inc (AXGN) in total and bought 0 shares, with a net sale of 118,082 shares. During the past 18 months, 322,478 shares of Axogen Inc (AXGN) were sold and 30,000 shares were bought by its insiders, resulting in a net sale of 292,478 shares.

Axogen Inc (AXGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Syros Pharmaceuticals Inc (SYRS). Other recent insider transactions involving Syros Pharmaceuticals Inc (SYRS) include a net sale of 30,523 shares made by David Roth , a net purchase of 904,977 shares made by Srinivas Akkaraju , and a net sale of 689 shares made by Eric R Olson .

In summary, during the past 3 months, insiders sold 10,601 shares of Syros Pharmaceuticals Inc (SYRS) in total and bought 0 shares, with a net sale of 10,601 shares. During the past 18 months, 31,212 shares of Syros Pharmaceuticals Inc (SYRS) were sold and 904,977 shares were bought by its insiders, resulting in a net purchase of 873,765 shares.

Syros Pharmaceuticals Inc (SYRS)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of XenoPort Inc (XNPT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of XenoPort Inc (XNPT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

XenoPort Inc (XNPT)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of AveXis Inc (AVXS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of AveXis Inc (AVXS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

AveXis Inc (AVXS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Editas Medicine Inc (EDIT). Other recent insider transactions involving Editas Medicine Inc (EDIT) include a net sale of 6,936 shares made by Bruce Eaton , a net sale of 7,365 shares made by Michelle Robertson , and a net sale of 84,310 shares made by Gilmore Neil O'neill .

In summary, during the past 3 months, insiders sold 98,151 shares of Editas Medicine Inc (EDIT) in total and bought 0 shares, with a net sale of 98,151 shares. During the past 18 months, 126,045 shares of Editas Medicine Inc (EDIT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 126,045 shares.

Editas Medicine Inc (EDIT)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Streamline Health Solutions Inc (STRM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Streamline Health Solutions Inc (STRM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Streamline Health Solutions Inc (STRM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Alimera Sciences Inc (ALIM). Other recent insider transactions involving Alimera Sciences Inc (ALIM) include a net sale of 0 shares made by Caligan Partners Lp , a net purchase of 1,401,901 shares made by Adam Morgan , and a net sale of 200,919 shares made by Palo Alto Investors, Llc .

In summary, during the past 3 months, insiders sold 0 shares of Alimera Sciences Inc (ALIM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 779,919 shares of Alimera Sciences Inc (ALIM) were sold and 1,980,901 shares were bought by its insiders, resulting in a net purchase of 1,200,982 shares.

Alimera Sciences Inc (ALIM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in CytomX Therapeutics Inc (CTMX). Other recent insider transactions involving CytomX Therapeutics Inc (CTMX) include a net sale of 55,496 shares made by Sean A. Mccarthy , a net sale of 16,868 shares made by Lloyd A Rowland , and a net sale of 16,235 shares made by Jeffrey B Landau .

In summary, during the past 3 months, insiders sold 47,819 shares of CytomX Therapeutics Inc (CTMX) in total and bought 0 shares, with a net sale of 47,819 shares. During the past 18 months, 121,072 shares of CytomX Therapeutics Inc (CTMX) were sold and 5,000 shares were bought by its insiders, resulting in a net sale of 116,072 shares.

CytomX Therapeutics Inc (CTMX)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Antares Pharma Inc (ATRS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Antares Pharma Inc (ATRS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Antares Pharma Inc (ATRS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Regenxbio Inc (RGNX). Other recent insider transactions involving Regenxbio Inc (RGNX) include a net sale of 135,000 shares made by Kenneth T. Mills , and a net sale of 12,878 shares made by Steve Pakola .

In summary, during the past 3 months, insiders sold 57,878 shares of Regenxbio Inc (RGNX) in total and bought 0 shares, with a net sale of 57,878 shares. During the past 18 months, 147,878 shares of Regenxbio Inc (RGNX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 147,878 shares.

Regenxbio Inc (RGNX)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Neos Therapeutics Inc (NEOS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Neos Therapeutics Inc (NEOS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Neos Therapeutics Inc (NEOS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in aTyr Pharma Inc (LIFE). Other recent insider transactions involving aTyr Pharma Inc (LIFE) include a net purchase of 55,000 shares made by Sanjay Shukla , a net sale of 3,156 shares made by Jill Marie Broadfoot , and a net purchase of 200,000 shares made by Paul Schimmel .

In summary, during the past 3 months, insiders sold 1,590 shares of aTyr Pharma Inc (LIFE) in total and bought 0 shares, with a net sale of 1,590 shares. During the past 18 months, 3,156 shares of aTyr Pharma Inc (LIFE) were sold and 255,000 shares were bought by its insiders, resulting in a net purchase of 251,844 shares.

aTyr Pharma Inc (LIFE)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of SteadyMed Ltd (STDY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of SteadyMed Ltd (STDY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

SteadyMed Ltd (STDY)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Invitae Corp (NVTAQ). Other recent insider transactions involving Invitae Corp (NVTAQ) include a net sale of 92,717 shares made by Kenneth D. Knight , a net sale of 89,529 shares made by Yafei Wen , and a net sale of 36,187 shares made by Robert L Nussbaum .

In summary, during the past 3 months, insiders sold 0 shares of Invitae Corp (NVTAQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 332,151 shares of Invitae Corp (NVTAQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 332,151 shares.

Invitae Corp (NVTAQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Dicerna Pharmaceuticals Inc (DRNA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Dicerna Pharmaceuticals Inc (DRNA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Dicerna Pharmaceuticals Inc (DRNA)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Loxo Oncology Inc (LOXO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Loxo Oncology Inc (LOXO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Loxo Oncology Inc (LOXO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Adverum Biotechnologies Inc (ADVM). Other recent insider transactions involving Adverum Biotechnologies Inc (ADVM) include a net purchase of 130,000 shares made by Lupher, Jr. Mark L. , a net purchase of 100,000 shares made by Linda M Rubinstein , and a net purchase of 100,000 shares made by James Paul Scopa .

In summary, during the past 3 months, insiders sold 0 shares of Adverum Biotechnologies Inc (ADVM) in total and bought 23,000 shares, with a net purchase of 23,000 shares. During the past 18 months, 6,810 shares of Adverum Biotechnologies Inc (ADVM) were sold and 33,000 shares were bought by its insiders, resulting in a net purchase of 26,190 shares.

Adverum Biotechnologies Inc (ADVM)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of TriVascular Technologies Inc (TRIV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of TriVascular Technologies Inc (TRIV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

TriVascular Technologies Inc (TRIV)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of NxStage Medical Inc (NXTM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of NxStage Medical Inc (NXTM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

NxStage Medical Inc (NXTM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Rigel Pharmaceuticals Inc (RIGL). Other recent insider transactions involving Rigel Pharmaceuticals Inc (RIGL) include a net sale of 73,234 shares made by Raul R Rodriguez , a net sale of 19,907 shares made by David A Santos , and a net sale of 18,017 shares made by Dean L Schorno .

In summary, during the past 3 months, insiders sold 80,041 shares of Rigel Pharmaceuticals Inc (RIGL) in total and bought 0 shares, with a net sale of 80,041 shares. During the past 18 months, 116,547 shares of Rigel Pharmaceuticals Inc (RIGL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 116,547 shares.

Rigel Pharmaceuticals Inc (RIGL)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of The Medicines Co (MDCO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of The Medicines Co (MDCO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

The Medicines Co (MDCO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in NeuroMetrix Inc (NURO). Other recent insider transactions involving NeuroMetrix Inc (NURO) include a net sale of 1,000 shares made by Joshua Horowitz ,

In summary, during the past 3 months, insiders sold 1,000 shares of NeuroMetrix Inc (NURO) in total and bought 0 shares, with a net sale of 1,000 shares. During the past 18 months, 1,000 shares of NeuroMetrix Inc (NURO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,000 shares.

NeuroMetrix Inc (NURO)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Fibrocell Science Inc (FCSC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Fibrocell Science Inc (FCSC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Fibrocell Science Inc (FCSC)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of NeurogesX Inc (NGSX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of NeurogesX Inc (NGSX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

NeurogesX Inc (NGSX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Cyclacel Pharmaceuticals Inc (CYCC). Other recent insider transactions involving Cyclacel Pharmaceuticals Inc (CYCC) include a net purchase of 6,070 shares made by Spiro Rombotis , and a net purchase of 1,886 shares made by Paul Mcbarron .

In summary, during the past 3 months, insiders sold 0 shares of Cyclacel Pharmaceuticals Inc (CYCC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cyclacel Pharmaceuticals Inc (CYCC) were sold and 7,956 shares were bought by its insiders, resulting in a net purchase of 7,956 shares.

Cyclacel Pharmaceuticals Inc (CYCC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Dynavax Technologies Corp (DVAX). Other recent insider transactions involving Dynavax Technologies Corp (DVAX) include a net sale of 238,719 shares made by David F Novack , a net sale of 46,327 shares made by Robert Janssen , and a net sale of 4,500,000 shares made by Hack Andrew A. F. .

In summary, during the past 3 months, insiders sold 20,526 shares of Dynavax Technologies Corp (DVAX) in total and bought 0 shares, with a net sale of 20,526 shares. During the past 18 months, 4,836,004 shares of Dynavax Technologies Corp (DVAX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 4,836,004 shares.

Dynavax Technologies Corp (DVAX)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of VIA Pharmaceuticals Inc (VIAP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of VIA Pharmaceuticals Inc (VIAP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

VIA Pharmaceuticals Inc (VIAP)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Arena Pharmaceuticals Inc (ARNA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Arena Pharmaceuticals Inc (ARNA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Arena Pharmaceuticals Inc (ARNA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Edgewise Therapeutics Inc (EWTX). Other recent insider transactions involving Edgewise Therapeutics Inc (EWTX) include a net sale of 42,185 shares made by John R Moore , a net sale of 175,763 shares made by Alan J Russell , and a net sale of 93,493 shares made by R Michael Carruthers .

In summary, during the past 3 months, insiders sold 54,076 shares of Edgewise Therapeutics Inc (EWTX) in total and bought 0 shares, with a net sale of 54,076 shares. During the past 18 months, 338,197 shares of Edgewise Therapeutics Inc (EWTX) were sold and 919,947 shares were bought by its insiders, resulting in a net purchase of 581,750 shares.

Edgewise Therapeutics Inc (EWTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made 1 insider transaction in AdaptHealth Corp (AHCO) with a net sale of 350,000. Other recent insider transactions involving AdaptHealth Corp (AHCO) include a net sale of 1,218,573 shares made by Everest Hill Group Inc. , a net sale of 325,627 shares made by Skyknight Aero Holdings, Llc , and a net sale of 200,000 shares made by Albert A. Prast .

In summary, during the past 3 months, insiders sold 350,000 shares of AdaptHealth Corp (AHCO) in total and bought 0 shares, with a net sale of 350,000 shares. During the past 18 months, 2,286,533 shares of AdaptHealth Corp (AHCO) were sold and 720 shares were bought by its insiders, resulting in a net sale of 2,285,813 shares.

AdaptHealth Corp (AHCO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Werewolf Therapeutics Inc (HOWL). Other recent insider transactions involving Werewolf Therapeutics Inc (HOWL) include a net purchase of 1,853,000 shares made by Ra Capital Healthcare Fund Lp ,

In summary, during the past 3 months, insiders sold 0 shares of Werewolf Therapeutics Inc (HOWL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Werewolf Therapeutics Inc (HOWL) were sold and 1,853,000 shares were bought by its insiders, resulting in a net purchase of 1,853,000 shares.

Werewolf Therapeutics Inc (HOWL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in The Oncology Institute Inc (TOI). Other recent insider transactions involving The Oncology Institute Inc (TOI) include a net sale of 728,469 shares made by Havencrest Healthcare Partners, L.p. , a net sale of 81,718 shares made by Brad Hively , and a net purchase of 73,107 shares made by Matthew P Miller .

In summary, during the past 3 months, insiders sold 0 shares of The Oncology Institute Inc (TOI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 830,914 shares of The Oncology Institute Inc (TOI) were sold and 223,684 shares were bought by its insiders, resulting in a net sale of 607,230 shares.

The Oncology Institute Inc (TOI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in CareMax Inc (CMAX). Other recent insider transactions involving CareMax Inc (CMAX) include a net purchase of 10,000 shares made by Bryan Cho ,

In summary, during the past 3 months, insiders sold 0 shares of CareMax Inc (CMAX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of CareMax Inc (CMAX) were sold and 333 shares were bought by its insiders, resulting in a net purchase of 333 shares.

CareMax Inc (CMAX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Terns Pharmaceuticals Inc (TERN). Other recent insider transactions involving Terns Pharmaceuticals Inc (TERN) include a net purchase of 10,743 shares made by Seokho Bryan Yoon , a net purchase of 10,743 shares made by Mark J. Vignola , and a net purchase of 337,957 shares made by Vivo Opportunity Fund Holdings, L.p. .

In summary, during the past 3 months, insiders sold 420,663 shares of Terns Pharmaceuticals Inc (TERN) in total and bought 0 shares, with a net sale of 420,663 shares. During the past 18 months, 1,920,663 shares of Terns Pharmaceuticals Inc (TERN) were sold and 1,816,702 shares were bought by its insiders, resulting in a net sale of 103,961 shares.

Terns Pharmaceuticals Inc (TERN)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Ignyte Acquisition Corp (IGNYU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ignyte Acquisition Corp (IGNYU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Ignyte Acquisition Corp (IGNYU)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in PepGen Inc (PEPG). Other recent insider transactions involving PepGen Inc (PEPG) include a net sale of 29,556 shares made by James G Mcarthur , a net sale of 6,392 shares made by Jaya Goyal , and a net purchase of 2,557,593 shares made by Ra Capital Healthcare Fund Lp .

In summary, during the past 3 months, insiders sold 0 shares of PepGen Inc (PEPG) in total and bought 2,557,593 shares, with a net purchase of 2,557,593 shares. During the past 18 months, 37,642 shares of PepGen Inc (PEPG) were sold and 2,559,287 shares were bought by its insiders, resulting in a net purchase of 2,521,645 shares.

PepGen Inc (PEPG)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Xilio Therapeutics Inc (XLO). Other recent insider transactions involving Xilio Therapeutics Inc (XLO) include a net sale of 5,235 shares made by Atlas Venture Fund Xi, L.p. , and a net purchase of 485,250 shares made by Gilead Sciences Inc .

In summary, during the past 3 months, insiders sold 1,000 shares of Xilio Therapeutics Inc (XLO) in total and bought 485,250 shares, with a net purchase of 484,250 shares. During the past 18 months, 5,235 shares of Xilio Therapeutics Inc (XLO) were sold and 485,250 shares were bought by its insiders, resulting in a net purchase of 480,015 shares.

Xilio Therapeutics Inc (XLO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Singular Genomics Systems Inc (OMIC). Other recent insider transactions involving Singular Genomics Systems Inc (OMIC) include a net purchase of 420,000 shares made by Eli N. Glezer , a net sale of 631,648 shares made by Kim P. Kamdar , and a net purchase of 118,468 shares made by Andrew Spaventa .

In summary, during the past 3 months, insiders sold 0 shares of Singular Genomics Systems Inc (OMIC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 631,648 shares of Singular Genomics Systems Inc (OMIC) were sold and 538,468 shares were bought by its insiders, resulting in a net sale of 93,180 shares.

Singular Genomics Systems Inc (OMIC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Nuvalent Inc (NUVL). Other recent insider transactions involving Nuvalent Inc (NUVL) include a net sale of 135,400 shares made by Darlene Noci , a net sale of 97,578 shares made by Deborah Ann Miller , and a net sale of 485,600 shares made by Matthew Shair .

In summary, during the past 3 months, insiders sold 1,175,333 shares of Nuvalent Inc (NUVL) in total and bought 0 shares, with a net sale of 1,175,333 shares. During the past 18 months, 1,700,471 shares of Nuvalent Inc (NUVL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,700,471 shares.

Nuvalent Inc (NUVL)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of DA32 Life Science Tech Acquisition Corp (DALS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of DA32 Life Science Tech Acquisition Corp (DALS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

DA32 Life Science Tech Acquisition Corp (DALS)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Ignyte Acquisition Corp (IGNY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ignyte Acquisition Corp (IGNY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Ignyte Acquisition Corp (IGNY)'s detailed insider trading history can be found in Insider Trading Tracker table.